||

Maryland Regulators Issue Guidance Ahead of Federal Hemp Redefinition

advertisement

Licensed cannabis dispensaries in Maryland will soon need to reorganize where and how they sell certain hemp-derived products under new guidance issued by the Maryland Cannabis Administration (MCA).

In a regulatory bulletin released Nov. 13, the MCA outlined compliance expectations for retail licensees ahead of a major federal change to the statutory definition of hemp set to take effect on Dec. 11, 2026.

Under the guidance, dispensaries that choose to sell hemp-derived items in their public waiting areas must restrict those shelves strictly to products that satisfy the revised federal definition of hemp and final hemp-derived cannabinoid products.

Any hemp-derived products that fall outside the new federal criteria may no longer be sold in public-facing lobby spaces. Instead, dispensaries may only sell those items inside the dispensary’s restricted service area—and only if the products comply with all MCA manufacturing, laboratory testing, packaging, and labeling rules.

To keep non-federally compliant hemp products on their menus, dispensary operators will need to coordinate with licensed processors to verify that the items meet state cannabis product standards before offering them to medical patients, caregivers, or adult-use consumers. For licensees opting not to carry those items under state cannabis rules, the MCA advised making arrangements to return non-compliant inventory to sellers before the Dec. 11 deadline.

Federal Statutory Changes

The MCA’s directive stems from federal legislation enacted by Congress on Nov. 12, 2025—the Continuing Appropriations, Agriculture, Legislative Branch, Military Construction and Veterans Affairs, and Extensions Act, 2026—which amended the federal definition of hemp under 7 U.S.C. § 1639o.

While the updated federal statute maintains the 0.3 percent dry-weight threshold, it now measures total tetrahydrocannabinol (THC), explicitly factoring in tetrahydrocannabinolic acid (THCA). More significantly, the law carves out sweeping exclusions for final hemp-derived cannabinoid products. Starting Dec. 11, products will be excluded from the federal definition of hemp if they contain:

  • Cannabinoids that cannot be naturally produced by the Cannabis sativa L. plant;
  • Naturally occurring cannabinoids that were synthesized or manufactured outside the plant; or
  • More than 0.4 milligrams combined total per container of total THC (including THCA) and any other cannabinoids that produce—or are marketed to produce—effects similar to THC in humans or animals, as determined by the Secretary of Health and Human Services.

The MCA noted that the tighter federal criteria will strip federal hemp status from numerous items previously marketed as compliant hemp products. Regulators urged dispensary licensees to audit the cannabinoid profiles and supporting documentation of their current inventory ahead of next month’s effective date.

Licensees with questions regarding the bulletin can contact the agency at mca.compliance@maryland.gov or mca.policy@maryland.gov.

cards
Powered by paypal

Find a licensed dispensary near you:

Did you know that the popular “gifting” shop model is no longer allowed under Washington, D.C. regulations? To find a legal medical cannabis provider or adult-use retailer, browse our maps of licensed dispensaries in D.C. and Maryland below:

Find the best legal weed near you:

We’re excited to announce the first edition of our new series, DMV’s Most Wanted, where we highlight the best legal weed products in the DMV, as nominated by our readers.

advertisement

Featured Business Member:

advertisement

advertisement